Timothy Fitzgibbons to Coronary Artery Disease
This is a "connection" page, showing publications Timothy Fitzgibbons has written about Coronary Artery Disease.
Connection Strength
1.361
-
Fitzgibbons TP. Epicardial Adipose-Derived miR92a-3p: Stress Reduction Therapy? J Am Coll Cardiol. 2023 07 25; 82(4):333-335.
Score: 0.610
-
Fitzgibbons TP, Lee N, Tran KV, Nicoloro S, Kelly M, Tam SK, Czech MP. Coronary disease is not associated with robust alterations in inflammatory gene expression in human epicardial fat. JCI Insight. 2019 10 17; 4(20).
Score: 0.469
-
Ihdayhid AR, Sellers SL, Polsani V, Fairbairn T, Khoo J, Fitzgibbons TP, Corrigan F, Ko B, Gooley R, Vucic E, Liu S, Coughlan F, Yong G, Shetty S, Chatfield A, Akodad M, Mohammadi A, Raju V, Lewin S, Blanke P, Kakouros N, Sathananthan J, Webb J, Wood D, Leipsic J. Feasibility and utility of anatomical and physiological evaluation of coronary artery disease with cardiac CT in severe aortic stenosis (FUTURE-AS registry). J Cardiovasc Comput Tomogr. 2026 Mar-Apr; 20(2):148-156.
Score: 0.181
-
Saddic LA, Nicoloro SM, Gupta OT, Czech MP, Gorham J, Shernan SK, Seidman CE, Seidman JG, Aranki SF, Body SC, Fitzgibbons TP, Muehlschlegel JD. Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia. Cardiovasc Diabetol. 2017 07 07; 16(1):87.
Score: 0.100